Clinical trial
Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People…
NCT00218218 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00218218 |
|---|---|
| Title | Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With Schizophrenia |
| Official title | Transdermal Nicotine and Bupropion for Smoking in Schizophrenics (Study 1) |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia and Disorders With Psychotic Features, Tobacco Use Disorder, Schizophrenia |
| Intervention type | Drug |
| Interventions | Transdermal Nicotine Patch, 21 mg transdermal nicotine, placebo patch |
| Enrollment | 48 |
| Start date | Jun 1, 2002 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: